PNT
POINT Biopharma Global Inc. Common Stock
Delisted
PNT was delisted on the 26th of December, 2023.
125 hedge funds and large institutions have $411M invested in POINT Biopharma Global Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 51 increasing their positions, 38 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
41% less call options, than puts
Call options by funds: $1.55M | Put options by funds: $2.64M
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Holders
125
Holding in Top 10
–
Calls
$1.55M
Puts
$2.64M
Top Buyers
| 1 | +$7.3M | |
| 2 | +$5.68M | |
| 3 | +$2.98M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$2.77M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$2.09M |
Top Sellers
| 1 | -$15.1M | |
| 2 | -$7.6M | |
| 3 | -$6.13M | |
| 4 |
Goldman Sachs
New York
|
-$4.78M |
| 5 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
-$3.11M |